Data on the association between CTRP1 and future major adverse cardiovascular events in patients undergoing coronary angiography

Axel Muendlein; Andreas Leiherer; Christoph Saely; Janine Ebner; Kathrin Geiger; Eva Maria Brandtner; Alexander Vonbank; Peter Fraunberger; Heinz Drexel

doi:10.1016/j.dib.2019.104109

Data on the association between CTRP1 and future major adverse cardiovascular events in patients undergoing coronary angiography

Data Brief. 2019 Jun 7:25:104109. doi: 10.1016/j.dib.2019.104109. eCollection 2019 Aug.

Authors

Axel Muendlein¹, Andreas Leiherer^{1

2

3}, Christoph Saely^{1

3

4

5}, Janine Ebner^{1

2}, Kathrin Geiger¹, Eva Maria Brandtner¹, Alexander Vonbank^{1

4}, Peter Fraunberger², Heinz Drexel^{1

3

5

6}

Affiliations

¹ Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria.
² Medical Central Laboratories, Feldkirch, Austria.
³ Private University of the Principality of Liechtenstein, Triesen, Liechtenstein.
⁴ Department of Medicine and Cardiology, Academic Teaching Hospital Feldkirch, Feldkirch, Austria.
⁵ Division of Angiology, Swiss Cardiovascular Center, University Hospital of Bern, Bern, Switzerland.
⁶ Drexel University College of Medicine, Philadelphia, PA, USA.

Abstract

This article provides additional data on the association of the new adipokine CTRP1 with the incidence of future major adverse cardiovascular events in a prospective cohort of patients undergoing coronary angiography. In this regard, multivariable Cox proportional hazards models taking into account cardiac risk markers are presented. Additionally, data on the impact of baseline variables including metabolic traits and co-morbidities on the incidence of future major adverse cardiovascular events are shown. This data article is associated to the research article titled 'The Novel Adipokine CTRP1 is Significantly Associated with the Incidence of Major Adverse Cardiovascular Events' Muendlein et al., 2019.

Keywords: Adipokine; CTRP1; Major adverse cardiovascular events; Prospective study; Risk factor.